ORCL(ORCL)
ORCL
Q3 2026 EPS Estimate
$1.72
Sep 8, 2026 · Reports after close
Revenue Estimate
$19.13B
FY2027E EPS$8.06
FY2028E EPS$10.92
Analyst Sentiment
Wall St. Consensus
Buy33 analysts·High coverage
72
Score
29 Buy (88%)4 Hold (12%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
2988%
Hold
412%
Sell
00%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$95.00
-39.1%
Consensus
$241.00
+54.5%
Bull
$325.00
+108.3%
12-Month Target Range33 analysts
$95.00$241.00$325.00
Current $155.99Consensus
Current Price
$155.99
Upside to Consensus
$85.01
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+33.23%
EPS+7.62%
FY2028
Rev+45.51%
EPS+35.57%
FY2029
Rev+38.14%
EPS+41.39%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $89.61B | $130.40B | $180.13B | $218.50B | $257.13B |
| Low | $88.62B | $119.29B | $146.59B | $189.93B | $223.51B |
| High | $90.39B | $138.65B | $200.49B | $231.56B | $272.50B |
| EBITDA Avg | $35.69B | $51.94B | $71.75B | $87.03B | $102.42B |
| Low | $35.30B | $47.51B | $58.39B | $75.65B | $89.02B |
| High | $36.00B | $55.22B | $79.85B | $92.23B | $108.54B |
| EBIT Avg | $26.06B | $37.93B | $52.39B | $63.55B | $74.79B |
| Low | $25.77B | $34.70B | $42.64B | $55.24B | $65.01B |
| High | $26.29B | $40.33B | $58.31B | $67.35B | $79.26B |
| Net Income Avg | $23.30B | $32.72B | $47.69B | $57.63B | $69.81B |
| Low | $22.82B | $24.67B | $30.78B | $47.83B | $57.95B |
| High | $23.78B | $35.69B | $53.27B | $62.11B | $75.24B |
| EPS Avg | $8.06 | $10.92 | $15.45 | $19.77 | $23.95 |
| Low | $7.83 | $8.46 | $10.56 | $16.41 | $19.88 |
| High | $8.16 | $12.24 | $18.27 | $21.31 | $25.81 |
| Analysts (Rev / EPS) | 32 / 26 | 30 / 24 | 22 / 11 | 11 / 7 | 19 / 9 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $19.13B | $21.16B | $23.22B | $26.29B | $27.17B | $30.56B | $34.35B | $39.42B |
| Low | $19.10B | $20.68B | $22.64B | $25.63B | $26.49B | $29.80B | $33.49B | $38.44B |
| High | $19.20B | $21.35B | $23.54B | $26.65B | $27.55B | $30.98B | $34.82B | $39.97B |
| EBITDA Avg | $7.62B | $8.43B | $9.25B | $10.47B | $10.82B | $12.17B | $13.68B | $15.70B |
| Low | $7.61B | $8.24B | $9.02B | $10.21B | $10.55B | $11.87B | $13.34B | $15.31B |
| High | $7.65B | $8.50B | $9.38B | $10.62B | $10.97B | $12.34B | $13.87B | $15.92B |
| EBIT Avg | $5.56B | $6.15B | $6.75B | $7.65B | $7.90B | $8.89B | $9.99B | $11.47B |
| Low | $5.55B | $6.01B | $6.58B | $7.46B | $7.71B | $8.67B | $9.74B | $11.18B |
| High | $5.58B | $6.21B | $6.85B | $7.75B | $8.01B | $9.01B | $10.13B | $11.62B |
| Net Income Avg | $5.05B | $5.51B | $6.00B | $6.91B | $6.53B | $7.32B | $8.38B | $9.83B |
| Low | $4.52B | $4.95B | $5.81B | $6.69B | $6.32B | $7.08B | $8.11B | $9.51B |
| High | $5.17B | $5.89B | $6.11B | $7.04B | $6.65B | $7.45B | $8.53B | $10.01B |
| EPS Avg | $1.73 | $1.89 | $2.06 | $2.37 | $2.24 | $2.51 | $2.87 | $3.37 |
| Low | $1.55 | $1.70 | $1.99 | $2.29 | $2.17 | $2.43 | $2.78 | $3.26 |
| High | $1.77 | $2.02 | $2.10 | $2.41 | $2.28 | $2.56 | $2.93 | $3.43 |
| Analysts (Rev / EPS) | 20 / 22 | 20 / 21 | 10 / 18 | 10 / 9 | 10 / 12 | 10 / 17 | 9 / 10 | 9 / 11 |